The obesity duopoly has been pierced as Amgen positions itself to have a drug on the market in a few years. While this adds ...

Most people who lose weight through dieting will see it creep back up, leading to a cycle of "yo-yo dieting" that's hard on ...

Joe Biden wants diabetes drugs that aid weight loss and treat obesity, such as Wegovy, to fall under Medicare and Medicaid.

Congress has been considering bipartisan solutions to help address the growing obesity problem for over a decade now.

A new study finds that higher intake of ultra-processed foods is associated with greater body mass index (BMI). The findings ...

Millions of obese Americans would get access to popular weekly injectables that would help them shed pounds quickly if a $35 ...

Although obesity remains one of our most pressing global health concerns, new research reveals an interesting twist.

More than 390 million children and adolescents were overweight or obese as of 2022, according to the World Health ...

The Biden administration is looking to expand access to anti-obesity GLP-1 drugs like Ozempic and Wegovy for people who have ...

A new weight loss drug called MariTide caused 20 percent weight loss in a recent trial, even better than Wegovy or Ozempic.

The Biden administration has proposed a new rule to “significantly” expand coverage of anti-obesity medications for Americans ...

Biohaven's pipeline includes Troriluzole for SCA, BHV-2100 for migraines, and Taldefgrobep Alfa for SMA. See why BHVN stock ...